Trial Profile
A Phase II Study Of Bendamustine HCl [hydrochloride] In Relapsed And Primary Refractory Hodgkin's disease
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 07 Jul 2008
Price :
$35
*
At a glance
- Drugs Bendamustine (Primary)
- Indications Hodgkin's disease
- Focus Therapeutic Use
- 07 Jul 2008 New trial record.